Efficacy and Safety of Xueshuanxinmaining Tablet for the Treatment of Stable Angina Pectoris
Status:
Not yet recruiting
Trial end date:
2021-10-01
Target enrollment:
Participant gender:
Summary
This study is a randomized, double-blind, placebo-controlled, parallel clinical trial in
Chinese population with stable angina pectoris. The purpose is to determine the efficacy and
safety of Xueshuanxinmaining tablet in the treatment of stable angina pectoris.
Phase:
Phase 4
Details
Lead Sponsor:
Guang'anmen Hospital of China Academy of Chinese Medical Sciences